ARTICANZ - Beta (ver 0.9)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - location/NSW/2170-Liverpool-Sydney-South-West-Private-Hospital
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
3
trial(s) found.
NCT05290597
Advanced
Phase 1
Recruiting
A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects with Advanced Solid Malignancies or Lymphomas (
CIBI363A101
)
anti-PD-1 IL-2-immunocytokine conjugate
Lymphoma
Solid tumour
NSW
2109 - North Ryde - Macquarie University Hospital
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
2170 - Liverpool - Sydney South West Private Hospital
2500 - Wollongong - Cancer Care Wollongong
NCT05277168
Advanced
Phase 1 / Phase 2
Recruiting
AN OPEN-LABEL, SINGLE-ARM, MULTI-CENTER PHASE I/IIA CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS (
SHR-A1904-I-104
)
anti-CLDN18.2 antibody-drug conjugate
Solid tumour
NSW
2031 - Randwick - Scientia Clinical Research Ltd
2065 - St Leonards - GenesisCare North Shore Private Hospital
2109 - North Ryde - Macquarie University Hospital
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital
2170 - Liverpool - Sydney South West Private Hospital
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital
VIC
3199 - Frankston - Peninsula Health Frankston Hospital
QLD
4215 - Southport - Gold Coast Private Hospital
WA
6009 - Nedlands - One Clinical Research
NCT04964375
Advanced
Phase 1
Unknown
A Phase 1, Open-Label Study of ABSK043 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Solid Tumor (
ABSK043-101
)
PD-L1 inhibitor,oral
Cancer
NSW
2170 - Liverpool - Sydney South West Private Hospital
VIC
3199 - Frankston - Peninsula Health Frankston Hospital
QLD
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (2)
Unknown (1)
Recruitment Country and State
NSW (3)
QLD (2)
VIC (2)
WA (1)
Phase
Phase 1 (2)
Phase 1 / Phase 2 (1)
Trial Type
Advanced (3)
Cancer Therapy Class
PD-1/PD-L1
67%
PD-1
33%
CLDN18.2
33%
PD-L1
33%
Facility
2170 - Liverpool - Sydney South West Private Hospital (3)
2109 - North Ryde - Macquarie University Hospital (2)
2145 - Westmead - The Crown Princess Mary Cancer Centre - Westmead Hospital (2)
3199 - Frankston - Peninsula Health Frankston Hospital (2)
2500 - Wollongong - Cancer Care Wollongong (1)
2031 - Randwick - Scientia Clinical Research Ltd (1)
2065 - St Leonards - GenesisCare North Shore Private Hospital (1)
2250 - Gosford - Central Coast Cancer Centre, Gosford Hospital (1)
4215 - Southport - Gold Coast Private Hospital (1)
6009 - Nedlands - One Clinical Research (1)
4101 - South Brisbane - Mater Hospital Brisbane / ICON Cancer Centre (1)
Cancer Type
Cancer
Solid tumour
Haematological malignancy
Lymphoma
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy